Biostar Pharma Reports Reverse Stock Split 1 for 3
Biostar Pharmaceuticals (NASDAQ GM: BSPM) a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-3, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on April 4, 2012.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.